Company intelligence / Profile preview

Zephyrus Innovations

Vancouver, British Columbia, Canada

Ownership: Private
Development stage: Other

Overview

The company received FDA clearance for its Aeroject 3ml auto-retractable safety syringe, designed to reduce needlestick injuries and exposure to infectious agents, making syringes safer for both clinicians and patients. VaporShield is claimed as the world’s first injectable closed system transfer device; both products aim to address long-standing hazards in healthcare through technical innovation

Therapeutic areas: Other
Modalities: Device
Industry: Consumable Medical Devices

Beyond the preview

Go deeper on Zephyrus Innovations.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zephyrus Innovations.

Explore the full profile